Slide Insurance CRO sells 11,250 shares after option exercise

Slide Insurance Holdings Chief Risk Officer Matthew Paul Larson reported option exercises and share sales in company stock.

Rhea-AI Filing Summary

Slide Insurance Holdings Chief Risk Officer Matthew Paul Larson reported option exercises and share sales in company stock. On March 3, he exercised 11,250 stock options and received 11,250 shares of common stock at an exercise price of $0.79 per share. He then sold 11,250 common shares in an open-market transaction at a weighted average price of $19.01 per share, with individual sale prices ranging from $19.00 to $19.04. After these transactions, he reported no directly held common stock, while continuing to hold stock options, including grants that are fully vested and others that vest in stages through July 2027.

Insider Trade Summary

Exercise and Sale: 11,250 shares ($205K approx. pre-tax spread)

Exercise and Sale 5 txns

Insider LARSON MATTHEW PAUL

Role Chief Risk Officer

Sold 11,250 shs ($214K)

Approx. gross sale proceeds $214K

Approx. exercise cost $9K

Approx. pre-tax spread $205K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	11,250	$0.00	$0.00
Exercise	Common Stock	11,250	$0.79	$9K
Sale	Common Stock	11,250	$19.01	$214K
holding	Stock Option (Right to Buy)	--	--	--
holding	Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 241,250 contracts for 165,000 underlying shares (Direct); Common Stock — 0 shares (Direct)

Footnotes (4)

1. F1. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $19.00 to $19.04 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
2. F2. The exercise price, expiration date and number of stock options reported herein differ from those previously reported on the Reporting Person's Form 3 due to an administrative error. This Form 4 reflects the correct exercise price, expiration date and number of stock options held as of such date.
3. F3. These stock options are fully vested and exercisable.
4. F4. Of the 55,000 stock options reported herein, 27,500 are vested and exercisable. The remaining 27,500 vest ratably on July 14, 2026 and July 14, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Slide Insurance (SLDE) report for Matthew Paul Larson?

Slide Insurance’s Chief Risk Officer Matthew Paul Larson exercised 11,250 stock options and acquired 11,250 common shares, then sold all 11,250 shares in an open-market transaction. The filing also updates and confirms details of his stock option grants and vesting terms.

How many Slide Insurance (SLDE) shares did Matthew Paul Larson sell and at what price?

Matthew Paul Larson sold 11,250 shares of Slide Insurance common stock. The weighted average sale price was $19.01 per share, with individual transaction prices ranging from $19.00 to $19.04 per share, according to the Form 4 footnote disclosure.

Did Matthew Paul Larson retain any Slide Insurance (SLDE) common stock after these transactions?

After the reported March 3 transactions, Matthew Paul Larson reported holding zero shares of Slide Insurance common stock directly. However, he continues to hold stock options in the company, including fully vested options and additional options scheduled to vest over time.

What stock options in Slide Insurance (SLDE) does Matthew Paul Larson currently hold?

The Form 4 shows Matthew Paul Larson holding multiple Slide Insurance stock option grants. One grant is fully vested and exercisable, while another 55,000-option grant includes 27,500 vested options and 27,500 options vesting ratably on July 14, 2026 and July 14, 2027.

Why does the Slide Insurance (SLDE) Form 4 mention an administrative error in prior filings?

The Form 4 explains that the exercise price, expiration date, and number of stock options differ from those on Larson’s prior Form 3 because of an administrative error. This filing corrects those details by reflecting the accurate option terms and number of options held as of that earlier date.

What was the nature of Matthew Paul Larson’s Slide Insurance (SLDE) stock sale?

The sale was classified as an open-market or private transaction under code “S.” He sold 11,250 shares of Slide Insurance common stock at a weighted average price of $19.01 per share, with the company noting precise trade prices ranged from $19.00 to $19.04.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 07:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LARSON MATTHEW PAUL

(Last) (First) (Middle)

4221 W BOY SCOUT BLVD

SUITE 200

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Risk Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		M		11,250	A	$0.79	11,250	D
Common Stock	03/03/2026		S		11,250	D	$19.01(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.79(2)	03/03/2026		M			11,250	(3)	02/21/2032(2)	Common Stock	11,250	$0	76,250(2)	D
Stock Option (Right to Buy)	$0.79(2)							(3)	02/24/2032(2)	Common Stock	110,000		110,000(2)	D
Stock Option (Right to Buy)	$1.38(2)							(4)	07/12/2033(2)	Common Stock	55,000		55,000(2)	D

Explanation of Responses:

1. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $19.00 to $19.04 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

2. The exercise price, expiration date and number of stock options reported herein differ from those previously reported on the Reporting Person's Form 3 due to an administrative error. This Form 4 reflects the correct exercise price, expiration date and number of stock options held as of such date.

3. These stock options are fully vested and exercisable.

4. Of the 55,000 stock options reported herein, 27,500 are vested and exercisable. The remaining 27,500 vest ratably on July 14, 2026 and July 14, 2027.

	/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.